173 related articles for article (PubMed ID: 33817715)
1. Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma.
Păvăleanu I; Lozneanu L; Balan RA; Giuşcă SE; Avădănei ER; Căruntu ID; Amălinei C
Rom J Morphol Embryol; 2020; 61(3):739-749. PubMed ID: 33817715
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the peritoneum adjacent to endometriotic lesions using antibodies for Ber-EP4 antigen, estrogen receptors, and progesterone receptors: implication of peritoneal metaplasia in the pathogenesis of endometriosis.
Nakayama K; Masuzawa H; Li SF; Yoshikawa F; Toki T; Nikaido T; Silverberg SG; Fujii S
Int J Gynecol Pathol; 1994 Oct; 13(4):348-58. PubMed ID: 7814197
[TBL] [Abstract][Full Text] [Related]
3. BMI-1 Expression Heterogeneity in Endometriosis-Related and Non-Endometriotic Ovarian Carcinoma.
Lozneanu L; Balan RA; Păvăleanu I; Giuşcă SE; Căruntu ID; Amalinei C
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199929
[TBL] [Abstract][Full Text] [Related]
4. Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.
Xiao W; Awadallah A; Xin W
Int J Clin Exp Pathol; 2012; 5(7):642-50. PubMed ID: 22977660
[TBL] [Abstract][Full Text] [Related]
5. The significance of immune microenvironment in patients with endometriosis.
Păvăleanu I; Balan RA; Grigoraş A; Balan TA; Amălinei C
Rom J Morphol Embryol; 2023; 64(3):343-354. PubMed ID: 37867352
[TBL] [Abstract][Full Text] [Related]
6. Is there a relationship in-between ovarian endometriosis and ovarian cancer? Immunohistochemical profile of four cases with coexisting ovarian endometriosis and cancer.
Penciu RC; Postolache I; Steriu L; Izvoranu S; Tica AA; Mocanu ID; Sârbu V; Deacu M; Tica I; Bălţătescu GI; Tica OS; Tica VI
Rom J Morphol Embryol; 2020; 61(1):157-165. PubMed ID: 32747907
[TBL] [Abstract][Full Text] [Related]
7. [Malignant transformation of ovarian endometriosis: a clinicopathologic analysis of 49 cases].
Shen YM; Wu XL; Xu L; Huang Q; Yu N; Yao XY; Xie YP
Ai Zheng; 2008 Oct; 27(10):1106-10. PubMed ID: 18851793
[TBL] [Abstract][Full Text] [Related]
8. Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study.
Samartzis N; Samartzis EP; Noske A; Fedier A; Dedes KJ; Caduff R; Fink D; Imesch P
Reprod Biol Endocrinol; 2012 Apr; 10():30. PubMed ID: 22520060
[TBL] [Abstract][Full Text] [Related]
9. Proliferative activity of postmenopausal endometriosis: a histopathologic and immunocytochemical study.
Toki T; Horiuchi A; Li SF; Nakayama K; Silverberg SG; Fujii S
Int J Gynecol Pathol; 1996 Jan; 15(1):45-53. PubMed ID: 8852446
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-to-mesenchymal transition contributes to the downregulation of progesterone receptor expression in endometriosis lesions.
Ma L; Andrieu T; McKinnon B; Duempelmann L; Peng RW; Wotzkow C; Müller C; Mueller MD
J Steroid Biochem Mol Biol; 2021 Sep; 212():105943. PubMed ID: 34144151
[TBL] [Abstract][Full Text] [Related]
11. Endometriosis-associated ovarian carcinoma: differential expression of vascular endothelial growth factor and estrogen/progesterone receptors.
Del Carmen MG; Smith Sehdev AE; Fader AN; Zahurak ML; Richardson M; Fruehauf JP; Montz FJ; Bristow RE
Cancer; 2003 Oct; 98(8):1658-63. PubMed ID: 14534882
[TBL] [Abstract][Full Text] [Related]
12. Steroid receptors and hormones in relation to cell proliferation and apoptosis in poorly differentiated epithelial ovarian tumors.
Lindgren P; Bäckström T; Mählck CG; Ridderheim M; Cajander S
Int J Oncol; 2001 Jul; 19(1):31-8. PubMed ID: 11408919
[TBL] [Abstract][Full Text] [Related]
13. Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor.
Senol S; Sayar I; Ceyran AB; Ibiloglu I; Akalin I; Firat U; Kosemetin D; Engin Zerk P; Aydin A
Int J Gynecol Pathol; 2016 May; 35(3):238-48. PubMed ID: 26367784
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.
Arias-Pulido H; Smith HO; Joste NE; Bocklage T; Qualls CR; Chavez A; Prossnitz ER; Verschraegen CF
Gynecol Oncol; 2009 Sep; 114(3):480-5. PubMed ID: 19560192
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical predictors of recurrent ovarian endometriomas after laparoscopic surgery].
Pshenichnyuk EY; Asaturova AV; Adamyan LV; Zaytsev NV
Arkh Patol; 2018; 80(4):14-20. PubMed ID: 30059067
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts.
Nezhat F; Cohen C; Rahaman J; Gretz H; Cole P; Kalir T
Cancer; 2002 Jun; 94(11):2935-40. PubMed ID: 12115382
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: a new quantitative method.
Nisolle M; Casanas-Roux F; Wyns C; de Menten Y; Mathieu PE; Donnez J
Fertil Steril; 1994 Oct; 62(4):751-9. PubMed ID: 7523199
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
De Sousa Damião R; Fujiyama Oshima CT; Stávale JN; Gonçalves WJ
Oncol Rep; 2007 Jul; 18(1):25-32. PubMed ID: 17549341
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.
Bhagat R; Premalata CS; Shilpa V; Pallavi VR; Ramesh G; Vijay CR; Krishnamoorthy L
Tumour Biol; 2013 Aug; 34(4):2459-68. PubMed ID: 23605324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
